Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Eikon Therapeutics
company
About
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
- Hayward,California,United States
- 251 - 500
- http://www.eikontx.com
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $518M
- Industries
- Biotechnology,Health Care,Life Science,Medical
- Founded date
- Jan 1, 2019
- Number Of Employee
- 251 - 500
- Operating Status
- Active
- Legal Name
- Eikon Therapeutics, Inc.
Eikon Therapeutics is a biopharmaceutical company employing revolutionary technology at the interface of biology, engineering, and chemistry to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes that enable real-time, molecular-resolution measurements of protein movement in living cells.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$666M
Eikon Therapeutics has raised a total of
$666M
in funding over 2 rounds. Their latest funding was raised on
Jan 6, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 6, 2022 | Series B | $518M | 18 | — | — | Detail |
| May 5, 2021 | Series A | $148M | 4 |
The Column Group
|
— | Detail |
| Jan 1, 2019 | Seed | — | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
4
0
Eikon Therapeutics has made 4 investments. Their most recent investment was on
Oct 19, 2018, when Dapper Labs raised $15M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Oct 19, 2018
Dapper Labs
|
Series A | $15M | Blockchain | — |
|
Mar 20, 2018
Dapper Labs
|
Series A | $12.85M | Blockchain | — |
|
Oct 4, 2017
Torch
|
Seed | $2.40M | Corporate Training | — |
|
Mar 14, 2014
Cruise
|
Seed | $4.30M | Artificial Intelligence | — |
Investors
Number of Lead Investors
Number of Investors
1
18
Eikon Therapeutics is funded by 18 investors.
Abu Dhabi Investment Authority
and AME Cloud Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Abu Dhabi Investment Authority
|
— | Series B |
AME Cloud Ventures
|
— | Series B |
Canada Pension Plan Investment Board
|
— | Series B |
E15 VC
|
— | Series B |
|
|
— | Series B |
|
|
— | Series B |
General Catalyst
|
— | Series B |
Harel Insurance Investments and Financial Services
|
— | Series B |
|
|
— | Series B |
Horizons Ventures
|
— | Series B |
Employee Profiles
Number of Employee Profiles
12
Eikon Therapeutics has 12 current employee profiles, including
Board member Fei-Fei Li
Board member
Board member
Board member
Executive
Board member
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
